HEADER OXIDOREDUCTASE/INHIBITOR 13-MAY-22 8CT4 TITLE CRYO-EM STRUCTURE OF MTB LPD BOUND TO INHIBITOR COMPLEX WITH 2-((2- TITLE 2 CYANO-N,5-DIMETHYL-1H-INDOLE)-7-SULFONAMIDO)-N-(4-(OXETAN-3-YL)-3,4- TITLE 3 DIHYDRO-2H-BENZO[B] [1,4]OXAZIN-7-YL)ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROLIPOYL DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: LPD,COMPONENT OF PEROXYNITRITE REDUCTASE/PEROXIDASE COMPLEX, COMPND 5 COMPONENT OF PNR/P,DIHYDROLIPOAMIDE DEHYDROGENASE,E3 COMPONENT OF COMPND 6 ALPHA-KETOACID DEHYDROGENASE COMPLEXES; COMPND 7 EC: 1.8.1.4; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 STRAIN: ATCC 25618 / H37RV; SOURCE 5 ATCC: 25618; SOURCE 6 GENE: LPDC, LPD, RV0462, MTV038.06; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS FLAVOPROTEIN, GLYCOLYSIS, REDOX-ACTIVE CENTER, OXIDOREDUCTASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR T.KOCHANCZYK,N.ARANGO,C.D.LIMA REVDAT 2 07-JUN-23 8CT4 1 JRNL REVDAT 1 25-MAY-22 8CT4 0 JRNL AUTH T.KOCHANCZYK,N.ARANGO,M.MICHINO,S.SUN,J.GINN,R.BRYK, JRNL AUTH 2 C.NATHAN,C.D.LIMA JRNL TITL CRYO-EM STRUCTURE OF MTB LPD BOUND TO THE INHIBITOR JRNL TITL 2 2-((2-CYANO-N,5-DIMETHYL-1H-INDOLE)-7-SULFONAMIDO) JRNL TITL 3 -N-(4-(OXETAN-3-YL)-3,4-DIHYDRO-2H-BENZO[B] JRNL TITL 4 [1,4]OXAZIN-7-YL)ACETAMIDE AT 2.17 ANGSTROM RESOLUTION JRNL REF NOT PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, RELION, PHENIX, COOT, REMARK 3 PHENIX, CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 7KMY REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : CORRELATION COEFFICIENT REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.170 REMARK 3 NUMBER OF PARTICLES : 117795 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8CT4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1000265185. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : DIHYDROLIPOYL DEHYDROGENASE IN REMARK 245 COMPLEX WITH 2-((2-CYANO-N,5-DIMETHYL-1H-INDOLE)-7-SULFONAMIDO)- REMARK 245 N-(4-(OXETAN-3-YL)-3,4-DIHYDRO-2H-BENZO[B] [1,4]OXAZIN-7-YL) REMARK 245 ACETAMIDE REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 3.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : TEMPERATURE 22 C, HUMIDITY REMARK 245 100%, WAIT TIME 8S, BLOT TIME: REMARK 245 3.5S REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : 2-((2-CYANO-N,5-DIMETHYL-1H REMARK 245 -INDOLE)-7-SULFONAMIDO)-N-(4-(OXETAN-3-YL)-3,4-DIHYDRO-2H- REMARK 245 BENZO[B] [1,4]OXAZIN-7-YL)ACETAMIDE PROVIDED BY THE TRI- REMARK 245 INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE (TRITDI.ORG) REMARK 245 CONTACT: JOHN GINN (JGINN@TRITDI.ORG) REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 10748 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 7066.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 22500 REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 681 O HOH A 915 1.99 REMARK 500 NH1 ARG A 93 O HOH A 601 2.09 REMARK 500 NH1 ARG B 93 O HOH B 601 2.09 REMARK 500 O HOH B 725 O HOH B 878 2.11 REMARK 500 O HOH B 777 O HOH B 784 2.11 REMARK 500 O HOH A 727 O HOH A 886 2.12 REMARK 500 O HOH A 782 O HOH A 793 2.13 REMARK 500 O HOH B 808 O HOH B 820 2.14 REMARK 500 OD1 ASP B 196 O HOH B 602 2.15 REMARK 500 OD1 ASP A 196 O HOH A 602 2.15 REMARK 500 O HOH A 642 O HOH A 673 2.15 REMARK 500 O HOH A 745 O HOH A 765 2.16 REMARK 500 O HOH B 699 O HOH B 777 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 35 -67.21 -136.08 REMARK 500 VAL A 44 19.92 -148.36 REMARK 500 THR A 63 -50.46 -141.04 REMARK 500 ASP A 117 -154.41 -155.60 REMARK 500 ALA A 141 58.38 -141.62 REMARK 500 SER A 155 -167.84 -167.01 REMARK 500 ALA A 266 59.67 -149.09 REMARK 500 LEU A 314 111.00 -165.39 REMARK 500 HIS A 460 74.12 -158.99 REMARK 500 LYS B 35 -67.34 -136.29 REMARK 500 VAL B 44 19.87 -148.34 REMARK 500 THR B 63 -50.12 -141.20 REMARK 500 ASP B 117 -154.51 -155.43 REMARK 500 ALA B 141 58.41 -141.62 REMARK 500 SER B 155 -167.62 -167.17 REMARK 500 ALA B 266 59.65 -149.18 REMARK 500 LEU B 314 111.14 -164.83 REMARK 500 HIS B 460 74.13 -159.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7KMY RELATED DB: PDB REMARK 900 STRUCTURE OF MTB LPD BOUND TO 010705 REMARK 900 RELATED ID: EMD-26981 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF MTB LPD BOUND TO INHIBITOR COMPLEX WITH 2-((2- REMARK 900 CYANO-N,5-DIMETHYL-1H-INDOLE)-7-SULFONAMIDO)-N-(4-(OXETAN-3-YL)-3,4- REMARK 900 DIHYDRO-2H-BENZO[B] [1,4]OXAZIN-7-YL)ACETAMIDE DBREF 8CT4 A 1 464 UNP P9WHH9 DLDH_MYCTU 1 464 DBREF 8CT4 B 1 464 UNP P9WHH9 DLDH_MYCTU 1 464 SEQADV 8CT4 GLY A -1 UNP P9WHH9 EXPRESSION TAG SEQADV 8CT4 SER A 0 UNP P9WHH9 EXPRESSION TAG SEQADV 8CT4 GLY B -1 UNP P9WHH9 EXPRESSION TAG SEQADV 8CT4 SER B 0 UNP P9WHH9 EXPRESSION TAG SEQRES 1 A 466 GLY SER MET THR HIS TYR ASP VAL VAL VAL LEU GLY ALA SEQRES 2 A 466 GLY PRO GLY GLY TYR VAL ALA ALA ILE ARG ALA ALA GLN SEQRES 3 A 466 LEU GLY LEU SER THR ALA ILE VAL GLU PRO LYS TYR TRP SEQRES 4 A 466 GLY GLY VAL CYS LEU ASN VAL GLY CYS ILE PRO SER LYS SEQRES 5 A 466 ALA LEU LEU ARG ASN ALA GLU LEU VAL HIS ILE PHE THR SEQRES 6 A 466 LYS ASP ALA LYS ALA PHE GLY ILE SER GLY GLU VAL THR SEQRES 7 A 466 PHE ASP TYR GLY ILE ALA TYR ASP ARG SER ARG LYS VAL SEQRES 8 A 466 ALA GLU GLY ARG VAL ALA GLY VAL HIS PHE LEU MET LYS SEQRES 9 A 466 LYS ASN LYS ILE THR GLU ILE HIS GLY TYR GLY THR PHE SEQRES 10 A 466 ALA ASP ALA ASN THR LEU LEU VAL ASP LEU ASN ASP GLY SEQRES 11 A 466 GLY THR GLU SER VAL THR PHE ASP ASN ALA ILE ILE ALA SEQRES 12 A 466 THR GLY SER SER THR ARG LEU VAL PRO GLY THR SER LEU SEQRES 13 A 466 SER ALA ASN VAL VAL THR TYR GLU GLU GLN ILE LEU SER SEQRES 14 A 466 ARG GLU LEU PRO LYS SER ILE ILE ILE ALA GLY ALA GLY SEQRES 15 A 466 ALA ILE GLY MET GLU PHE GLY TYR VAL LEU LYS ASN TYR SEQRES 16 A 466 GLY VAL ASP VAL THR ILE VAL GLU PHE LEU PRO ARG ALA SEQRES 17 A 466 LEU PRO ASN GLU ASP ALA ASP VAL SER LYS GLU ILE GLU SEQRES 18 A 466 LYS GLN PHE LYS LYS LEU GLY VAL THR ILE LEU THR ALA SEQRES 19 A 466 THR LYS VAL GLU SER ILE ALA ASP GLY GLY SER GLN VAL SEQRES 20 A 466 THR VAL THR VAL THR LYS ASP GLY VAL ALA GLN GLU LEU SEQRES 21 A 466 LYS ALA GLU LYS VAL LEU GLN ALA ILE GLY PHE ALA PRO SEQRES 22 A 466 ASN VAL GLU GLY TYR GLY LEU ASP LYS ALA GLY VAL ALA SEQRES 23 A 466 LEU THR ASP ARG LYS ALA ILE GLY VAL ASP ASP TYR MET SEQRES 24 A 466 ARG THR ASN VAL GLY HIS ILE TYR ALA ILE GLY ASP VAL SEQRES 25 A 466 ASN GLY LEU LEU GLN LEU ALA HIS VAL ALA GLU ALA GLN SEQRES 26 A 466 GLY VAL VAL ALA ALA GLU THR ILE ALA GLY ALA GLU THR SEQRES 27 A 466 LEU THR LEU GLY ASP HIS ARG MET LEU PRO ARG ALA THR SEQRES 28 A 466 PHE CYS GLN PRO ASN VAL ALA SER PHE GLY LEU THR GLU SEQRES 29 A 466 GLN GLN ALA ARG ASN GLU GLY TYR ASP VAL VAL VAL ALA SEQRES 30 A 466 LYS PHE PRO PHE THR ALA ASN ALA LYS ALA HIS GLY VAL SEQRES 31 A 466 GLY ASP PRO SER GLY PHE VAL LYS LEU VAL ALA ASP ALA SEQRES 32 A 466 LYS HIS GLY GLU LEU LEU GLY GLY HIS LEU VAL GLY HIS SEQRES 33 A 466 ASP VAL ALA GLU LEU LEU PRO GLU LEU THR LEU ALA GLN SEQRES 34 A 466 ARG TRP ASP LEU THR ALA SER GLU LEU ALA ARG ASN VAL SEQRES 35 A 466 HIS THR HIS PRO THR MET SER GLU ALA LEU GLN GLU CYS SEQRES 36 A 466 PHE HIS GLY LEU VAL GLY HIS MET ILE ASN PHE SEQRES 1 B 466 GLY SER MET THR HIS TYR ASP VAL VAL VAL LEU GLY ALA SEQRES 2 B 466 GLY PRO GLY GLY TYR VAL ALA ALA ILE ARG ALA ALA GLN SEQRES 3 B 466 LEU GLY LEU SER THR ALA ILE VAL GLU PRO LYS TYR TRP SEQRES 4 B 466 GLY GLY VAL CYS LEU ASN VAL GLY CYS ILE PRO SER LYS SEQRES 5 B 466 ALA LEU LEU ARG ASN ALA GLU LEU VAL HIS ILE PHE THR SEQRES 6 B 466 LYS ASP ALA LYS ALA PHE GLY ILE SER GLY GLU VAL THR SEQRES 7 B 466 PHE ASP TYR GLY ILE ALA TYR ASP ARG SER ARG LYS VAL SEQRES 8 B 466 ALA GLU GLY ARG VAL ALA GLY VAL HIS PHE LEU MET LYS SEQRES 9 B 466 LYS ASN LYS ILE THR GLU ILE HIS GLY TYR GLY THR PHE SEQRES 10 B 466 ALA ASP ALA ASN THR LEU LEU VAL ASP LEU ASN ASP GLY SEQRES 11 B 466 GLY THR GLU SER VAL THR PHE ASP ASN ALA ILE ILE ALA SEQRES 12 B 466 THR GLY SER SER THR ARG LEU VAL PRO GLY THR SER LEU SEQRES 13 B 466 SER ALA ASN VAL VAL THR TYR GLU GLU GLN ILE LEU SER SEQRES 14 B 466 ARG GLU LEU PRO LYS SER ILE ILE ILE ALA GLY ALA GLY SEQRES 15 B 466 ALA ILE GLY MET GLU PHE GLY TYR VAL LEU LYS ASN TYR SEQRES 16 B 466 GLY VAL ASP VAL THR ILE VAL GLU PHE LEU PRO ARG ALA SEQRES 17 B 466 LEU PRO ASN GLU ASP ALA ASP VAL SER LYS GLU ILE GLU SEQRES 18 B 466 LYS GLN PHE LYS LYS LEU GLY VAL THR ILE LEU THR ALA SEQRES 19 B 466 THR LYS VAL GLU SER ILE ALA ASP GLY GLY SER GLN VAL SEQRES 20 B 466 THR VAL THR VAL THR LYS ASP GLY VAL ALA GLN GLU LEU SEQRES 21 B 466 LYS ALA GLU LYS VAL LEU GLN ALA ILE GLY PHE ALA PRO SEQRES 22 B 466 ASN VAL GLU GLY TYR GLY LEU ASP LYS ALA GLY VAL ALA SEQRES 23 B 466 LEU THR ASP ARG LYS ALA ILE GLY VAL ASP ASP TYR MET SEQRES 24 B 466 ARG THR ASN VAL GLY HIS ILE TYR ALA ILE GLY ASP VAL SEQRES 25 B 466 ASN GLY LEU LEU GLN LEU ALA HIS VAL ALA GLU ALA GLN SEQRES 26 B 466 GLY VAL VAL ALA ALA GLU THR ILE ALA GLY ALA GLU THR SEQRES 27 B 466 LEU THR LEU GLY ASP HIS ARG MET LEU PRO ARG ALA THR SEQRES 28 B 466 PHE CYS GLN PRO ASN VAL ALA SER PHE GLY LEU THR GLU SEQRES 29 B 466 GLN GLN ALA ARG ASN GLU GLY TYR ASP VAL VAL VAL ALA SEQRES 30 B 466 LYS PHE PRO PHE THR ALA ASN ALA LYS ALA HIS GLY VAL SEQRES 31 B 466 GLY ASP PRO SER GLY PHE VAL LYS LEU VAL ALA ASP ALA SEQRES 32 B 466 LYS HIS GLY GLU LEU LEU GLY GLY HIS LEU VAL GLY HIS SEQRES 33 B 466 ASP VAL ALA GLU LEU LEU PRO GLU LEU THR LEU ALA GLN SEQRES 34 B 466 ARG TRP ASP LEU THR ALA SER GLU LEU ALA ARG ASN VAL SEQRES 35 B 466 HIS THR HIS PRO THR MET SER GLU ALA LEU GLN GLU CYS SEQRES 36 B 466 PHE HIS GLY LEU VAL GLY HIS MET ILE ASN PHE HET FAD A 501 84 HET OU6 A 502 60 HET OU6 B 501 60 HET FAD B 502 84 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM OU6 N~2~-(2-CYANO-5-METHYL-1H-INDOLE-7-SULFONYL)-N~2~- HETNAM 2 OU6 METHYL-N-[4-(OXETAN-3-YL)-3,4-DIHYDRO-2H-1,4- HETNAM 3 OU6 BENZOXAZIN-7-YL]GLYCINAMIDE FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 4 OU6 2(C24 H25 N5 O5 S) FORMUL 7 HOH *665(H2 O) HELIX 1 AA1 GLY A 12 LEU A 25 1 14 HELIX 2 AA2 GLY A 38 GLY A 45 1 8 HELIX 3 AA3 GLY A 45 ASP A 65 1 21 HELIX 4 AA4 ASP A 65 GLY A 70 1 6 HELIX 5 AA5 ASP A 78 ASN A 104 1 27 HELIX 6 AA6 THR A 160 LEU A 166 1 7 HELIX 7 AA7 GLY A 180 TYR A 193 1 14 HELIX 8 AA8 ASP A 211 GLY A 226 1 16 HELIX 9 AA9 GLY A 308 ASN A 311 5 4 HELIX 10 AB1 LEU A 316 GLY A 333 1 18 HELIX 11 AB2 ASP A 341 LEU A 345 5 5 HELIX 12 AB3 THR A 361 GLU A 368 1 8 HELIX 13 AB4 ASN A 382 GLY A 389 1 8 HELIX 14 AB5 ASP A 415 GLU A 418 5 4 HELIX 15 AB6 LEU A 419 TRP A 429 1 11 HELIX 16 AB7 THR A 432 ALA A 437 1 6 HELIX 17 AB8 SER A 447 GLY A 459 1 13 HELIX 18 AB9 GLY B 12 LEU B 25 1 14 HELIX 19 AC1 GLY B 38 GLY B 45 1 8 HELIX 20 AC2 GLY B 45 GLY B 70 1 26 HELIX 21 AC3 ASP B 78 ASN B 104 1 27 HELIX 22 AC4 THR B 160 LEU B 166 1 7 HELIX 23 AC5 GLY B 180 TYR B 193 1 14 HELIX 24 AC6 ASP B 211 GLY B 226 1 16 HELIX 25 AC7 GLY B 308 ASN B 311 5 4 HELIX 26 AC8 LEU B 316 GLY B 333 1 18 HELIX 27 AC9 ASP B 341 LEU B 345 5 5 HELIX 28 AD1 THR B 361 GLU B 368 1 8 HELIX 29 AD2 ASN B 382 GLY B 389 1 8 HELIX 30 AD3 ASP B 415 GLU B 418 5 4 HELIX 31 AD4 LEU B 419 TRP B 429 1 11 HELIX 32 AD5 THR B 432 ALA B 437 1 6 HELIX 33 AD6 SER B 447 GLY B 459 1 13 SHEET 1 AA1 6 THR A 107 ILE A 109 0 SHEET 2 AA1 6 THR A 29 VAL A 32 1 N ILE A 31 O THR A 107 SHEET 3 AA1 6 THR A 2 LEU A 9 1 N VAL A 8 O VAL A 32 SHEET 4 AA1 6 THR A 130 ILE A 140 1 O ILE A 139 N LEU A 9 SHEET 5 AA1 6 THR A 120 LEU A 125 -1 N VAL A 123 O GLU A 131 SHEET 6 AA1 6 GLY A 111 PHE A 115 -1 N THR A 114 O LEU A 122 SHEET 1 AA2 5 THR A 107 ILE A 109 0 SHEET 2 AA2 5 THR A 29 VAL A 32 1 N ILE A 31 O THR A 107 SHEET 3 AA2 5 THR A 2 LEU A 9 1 N VAL A 8 O VAL A 32 SHEET 4 AA2 5 THR A 130 ILE A 140 1 O ILE A 139 N LEU A 9 SHEET 5 AA2 5 ILE A 304 ALA A 306 1 O TYR A 305 N ILE A 140 SHEET 1 AA3 2 ILE A 71 SER A 72 0 SHEET 2 AA3 2 THR B 76 PHE B 77 -1 O THR B 76 N SER A 72 SHEET 1 AA4 2 THR A 76 PHE A 77 0 SHEET 2 AA4 2 ILE B 71 SER B 72 -1 O SER B 72 N THR A 76 SHEET 1 AA5 2 SER A 144 THR A 146 0 SHEET 2 AA5 2 PHE A 269 PRO A 271 -1 O ALA A 270 N SER A 145 SHEET 1 AA6 5 VAL A 158 VAL A 159 0 SHEET 2 AA6 5 LYS A 262 GLN A 265 1 O GLN A 265 N VAL A 159 SHEET 3 AA6 5 SER A 173 ALA A 177 1 N ALA A 177 O LEU A 264 SHEET 4 AA6 5 ASP A 196 VAL A 200 1 O THR A 198 N ILE A 176 SHEET 5 AA6 5 THR A 228 LEU A 230 1 O LEU A 230 N ILE A 199 SHEET 1 AA7 3 LYS A 234 ASP A 240 0 SHEET 2 AA7 3 VAL A 245 LYS A 251 -1 O THR A 248 N GLU A 236 SHEET 3 AA7 3 VAL A 254 ALA A 260 -1 O GLN A 256 N VAL A 249 SHEET 1 AA8 5 ARG A 347 THR A 349 0 SHEET 2 AA8 5 ASN A 354 GLY A 359 -1 O VAL A 355 N THR A 349 SHEET 3 AA8 5 LEU A 406 GLY A 413 -1 O LEU A 411 N ALA A 356 SHEET 4 AA8 5 PHE A 394 ASP A 400 -1 N VAL A 398 O LEU A 407 SHEET 5 AA8 5 VAL A 372 PRO A 378 -1 N PHE A 377 O VAL A 395 SHEET 1 AA9 6 THR B 107 ILE B 109 0 SHEET 2 AA9 6 THR B 29 VAL B 32 1 N ILE B 31 O THR B 107 SHEET 3 AA9 6 HIS B 3 LEU B 9 1 N VAL B 8 O VAL B 32 SHEET 4 AA9 6 THR B 130 ILE B 140 1 O ILE B 139 N LEU B 9 SHEET 5 AA9 6 THR B 120 LEU B 125 -1 N VAL B 123 O GLU B 131 SHEET 6 AA9 6 GLY B 111 PHE B 115 -1 N THR B 114 O LEU B 122 SHEET 1 AB1 5 THR B 107 ILE B 109 0 SHEET 2 AB1 5 THR B 29 VAL B 32 1 N ILE B 31 O THR B 107 SHEET 3 AB1 5 HIS B 3 LEU B 9 1 N VAL B 8 O VAL B 32 SHEET 4 AB1 5 THR B 130 ILE B 140 1 O ILE B 139 N LEU B 9 SHEET 5 AB1 5 ILE B 304 ALA B 306 1 O TYR B 305 N ILE B 140 SHEET 1 AB2 2 SER B 144 THR B 146 0 SHEET 2 AB2 2 PHE B 269 PRO B 271 -1 O ALA B 270 N SER B 145 SHEET 1 AB3 5 VAL B 158 VAL B 159 0 SHEET 2 AB3 5 LYS B 262 GLN B 265 1 O GLN B 265 N VAL B 159 SHEET 3 AB3 5 SER B 173 ALA B 177 1 N ALA B 177 O LEU B 264 SHEET 4 AB3 5 ASP B 196 VAL B 200 1 O THR B 198 N ILE B 176 SHEET 5 AB3 5 THR B 228 LEU B 230 1 O LEU B 230 N ILE B 199 SHEET 1 AB4 3 LYS B 234 ASP B 240 0 SHEET 2 AB4 3 VAL B 245 LYS B 251 -1 O THR B 248 N GLU B 236 SHEET 3 AB4 3 VAL B 254 ALA B 260 -1 O GLN B 256 N VAL B 249 SHEET 1 AB5 5 ARG B 347 THR B 349 0 SHEET 2 AB5 5 ASN B 354 GLY B 359 -1 O VAL B 355 N THR B 349 SHEET 3 AB5 5 LEU B 406 GLY B 413 -1 O LEU B 411 N ALA B 356 SHEET 4 AB5 5 PHE B 394 ASP B 400 -1 N VAL B 398 O LEU B 407 SHEET 5 AB5 5 VAL B 372 PRO B 378 -1 N PHE B 377 O VAL B 395 CISPEP 1 GLN A 352 PRO A 353 0 4.51 CISPEP 2 HIS A 443 PRO A 444 0 -9.57 CISPEP 3 GLN B 352 PRO B 353 0 4.59 CISPEP 4 HIS B 443 PRO B 444 0 -9.46 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000